Laboratorios Farmaceuticos Rovi SA
![Laboratorios Farmaceuticos Rovi SA](https://api.admiralmarkets.com/trade_icons/bright-128/ROVI.png)
Suletud
80.2 1.84
Ülevaade
Aktsiahinna muutus
24h
Min
80.15
Max
80.45
Sissetulek | 15M |
---|---|
Müük | -297M 151M |
P/E Sektori keskmine | 24.61 |
Aktsiakasum | 0.292 |
Kasumimarginaal | 9.896 |
EBITDA | 26M |
Soovitused | Osta |
---|---|
12 kuu keskmine prognoos | +22.52 upside |
Turukapital | -23M 4.1B |
---|---|
Eelmine avamishind | 78.36 |
Eelmine sulgemishind | 80.2 |
Uudiste sentiment
By Acuity
50%
50%
Tehniline skoor
By Trading Central
Kindlus
Strong Bullish Evidence
Laboratorios Farmaceuticos Rovi SA Graafik
Seotud uudised
Laboratorios Farmaceuticos Rovi SA Prognoos
Hinnasiht
By TipRanks
22.52% tõus
12 kuu keskmine prognoos
Keskmine 99 EUR 22.52%
Kõrge 104 EUR
Madal 94 EUR
Põhineb 2 Wall Streeti analüütiku instrumendi Laboratorios Farmaceuticos Rovi SA 12 kuu hinnasihil - viimase 3 kuu andmed.
Sentiment
By Acuity
Uudiste sentiment
Neutral
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Üle keskmise
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
EBITDA
Ärikasum
$
Ettevõttest Laboratorios Farmaceuticos Rovi SA
Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.